miR-375 is a key downstream effector of ASH1 function in lung cancer cells; the transcriptional coactivator YAP1 was determined to be a direct target of miR-375

Decreased miR-375 correlated significantly with advanced disease stage and lymphatic metastasis in nonsmall cell lung cancer.

Levels of MiR-375 distinguishes squamous cell carcinoma from adenocarcinoma in lung cancer biopsies.

study demonstrates the differential expression profiles of miR-375 in 3 subtypes of lung carcinomas and finds thatmiR-375 directly targets ITPKB and promoted cell growth in SCLC cell line.

This study provides evidence that miR-375 is essential for the progression of lung adenocarcinoma.

study demonstrated that miR-375 may play an important role as a predictive biomarker in brain metastasis and an independent prognostic factor in non-small cell lung cancer

miR-375 inhibits tumor progression in gastric, prostate, breast, lung, and head and neck cancers. Overexpression of miR-375 significantly suppressed proliferation in an established gastric cancer xenograft nude mouse model.

Circulating miR-92b and miR-375 for monitoring the chemoresistance and prognosis of small cell lung cancer.

Circ_0086720 knockdown strengthens the radiosensitivity of non-small cell lung cancer via mediating the miR-375/SPIN1 axis.